Welcome to LookChem.com Sign In|Join Free
  • or
Pyridine, 5-(4-fluorophenoxy)-2-methoxy- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

879893-91-1

Post Buying Request

879893-91-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

879893-91-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 879893-91-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,9,8,9 and 3 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 879893-91:
(8*8)+(7*7)+(6*9)+(5*8)+(4*9)+(3*3)+(2*9)+(1*1)=271
271 % 10 = 1
So 879893-91-1 is a valid CAS Registry Number.

879893-91-1Downstream Products

879893-91-1Relevant academic research and scientific papers

(2-Pyridyl)acetone-promoted Cu-catalyzed O-arylation of phenols with aryl iodides, bromides, and chlorides

Zhang, Qi,Wang, Deping,Wang, Xianyang,Ding, Ke

supporting information; experimental part, p. 7187 - 7190 (2009/12/09)

(Chemical Equation Presented) Employing (2-pyridyl)acetone as a new supporting ligand, the copper-catalyzed coupling reactions of aryl chlorides, aryl bromides, and aryl iodides with various phenols successfully proceeded in good yields under mild conditions. This reaction displays great functional groups compatibility and excellent reactive selectivity.

NOVEL PYRIDINONE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2-RECEPTORS

-

Page/Page column 137, (2010/10/20)

The present invention relates to novel compounds, in particular novel pyridinone derivat ives according to Formula (I) X R1 N Y (I) R2 R3 wherein all radicals are defined in the application. The compounds according to the invention are positive allosteric modulators of metabotropic receptors-subt ype 2 ("mGluR2") which are useful for the treatment or prevention of neurological and psychiatric disorders associated with glutamate dysfunction and diseases in which the mGluR2 subtype of metabotropic receptors is involved. In particular, such diseases are central nervous system disorders selected from the group of anxiety, schizophrenia, migraine, depression, and epilepsy. The invention is also directed to pharmaceutical compositions and processes to prepare such compounds and compositions, as well as to the use of such compounds for the prevention and treatment of such diseases in which mGluR2 is involved. "

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 879893-91-1